Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity Completed Phase 2 Trials for Ispinesib (DB06188)

IndicationStatusPhase
DBCOND0029849 (Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00095628SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck CancerTreatment